<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-6.anc" start="29970" end="29974" sStart="29757" offset="213" sid="r7.1.use.v.0421" wn="1" wnkey="use%2:34:01::" annotator="veweser" text="In subsequent steps, motifs identified by sequence alignment programs like MEME (Multiple EM for Motif Elicitation), http://meme.sdsc.edu/meme/website/intro.htmlcan also be used to search the available databases using MAST (Motif Alignment and Search Tool, http://meme.sdsc.edu/mem/website/mast-intro.html)." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-6.anc" start="30390" end="30394" sStart="null" offset="56" sid="r7.1.use.v.0182" wn="1" wnkey="use%2:34:01::" annotator="jeneale" text="For Patternfind, the following parameters are used:" />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-6.anc" start="26612" end="26623" sStart="null" offset="0" sid="null" wn="2 3" wnkey="null" annotator="carichter" text="For phage rescue prior to ELISA analysis, 40 ?l of master stock is &lt;b&gt;transferred&lt;/b&gt; from each master to another set of cluster tubes containing 400 ?l of 2x YT-AG (ampicillin and glucose) and helper phage (final concentration of 5 ? 10 10/ml)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6750-1-6.anc" start="17987" end="17992" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" annotator="rstandig" text="Most of our surrogates have been &lt;b&gt;shown&lt;/b&gt; to have either agonist or antagonist activity in the appropriate biochemical and/or biological models ( [ 7 ] manuscripts in preparation)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6750-1-6.anc" start="17987" end="17992" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" annotator="elstickles" text="Most of our surrogates have been &lt;b&gt;shown&lt;/b&gt; to have either agonist or antagonist activity in the appropriate biochemical and/or biological models ( [ 7 ] manuscripts in preparation)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6750-1-6.anc" start="17987" end="17992" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" annotator="comcgeetubb" text="Most of our surrogates have been &lt;b&gt;shown&lt;/b&gt; to have either agonist or antagonist activity in the appropriate biochemical and/or biological models ( [ 7 ] manuscripts in preparation)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6750-1-6.anc" start="17987" end="17992" sStart="null" offset="0" sid="null" wn="3" wnkey="show%2:32:00::" annotator="cgozo" text="Most of our surrogates have been &lt;b&gt;shown&lt;/b&gt; to have either agonist or antagonist activity in the appropriate biochemical and/or biological models ( [ 7 ] manuscripts in preparation)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6750-1-6.anc" start="17987" end="17992" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" annotator="carichter" text="Most of our surrogates have been &lt;b&gt;shown&lt;/b&gt; to have either agonist or antagonist activity in the appropriate biochemical and/or biological models ( [ 7 ] manuscripts in preparation)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6750-1-6.anc" start="17987" end="17992" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" annotator="brubin" text="Most of our surrogates have been &lt;b&gt;shown&lt;/b&gt; to have either agonist or antagonist activity in the appropriate biochemical and/or biological models ( [ 7 ] manuscripts in preparation)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-6.anc" start="19261" end="19266" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="veweser" text="This non-random association between a surrogate and a target's pharmacologically active site assures a high degree of probability that, once found, surrogates will have utility for the &lt;b&gt;rapid&lt;/b&gt; development of SDAs capable of identifying small molecules of pharmacological importance." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-6.anc" start="19261" end="19266" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="tofox" text="This non-random association between a surrogate and a target's pharmacologically active site assures a high degree of probability that, once found, surrogates will have utility for the &lt;b&gt;rapid&lt;/b&gt; development of SDAs capable of identifying small molecules of pharmacological importance." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-6.anc" start="22599" end="22605" sStart="null" offset="90" sid="r8.number.n.0645" wn="1" wnkey="number%1:07:00::" annotator="veweser" text="Cell transformants were pooled and an aliquot was plated to determine the total number of transformants." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-6.anc" start="3120" end="3126" sStart="null" offset="134" sid="r8.number.n.0065" wn="1" wnkey="number%1:07:00::" annotator="veweser" text="In addition, we examine each peptide for significant differences in the expected frequency of amino acids and the number of times a specific peptide sequence has been repeated." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-6.anc" start="3120" end="3126" sStart="null" offset="134" sid="r8.number.n.0065" wn="1" wnkey="number%1:07:00::" annotator="jeneale" text="In addition, we examine each peptide for significant differences in the expected frequency of amino acids and the number of times a specific peptide sequence has been repeated." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-6.anc" start="3120" end="3126" sStart="null" offset="134" sid="r8.number.n.0065" wn="1" wnkey="number%1:07:00::" annotator="cgozo" text="In addition, we examine each peptide for significant differences in the expected frequency of amino acids and the number of times a specific peptide sequence has been repeated." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-6.anc" start="17343" end="17350" sStart="null" offset="82" sid="r8.number.n.0823" wn="1" wnkey="number%1:07:00::" annotator="brubin" text="With that in mind, it may require the isolation and sequencing of large numbers of clones (perhaps &gt;500/target) in order to find the appropriate surrogate for partner identification." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-6.anc" start="3120" end="3126" sStart="null" offset="134" sid="r8.number.n.0065" wn="1" wnkey="number%1:07:00::" annotator="brubin" text="In addition, we examine each peptide for significant differences in the expected frequency of amino acids and the number of times a specific peptide sequence has been repeated." />
  </sentences>
</list>